Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

Improving medical students' written communication skills: design and evaluation of an educational curriculum.

Melvin L, Connolly K, Pitre L, Dore KL, Wasi P.

Postgrad Med J. 2015 Mar 26. pii: postgradmedj-2014-132983. doi: 10.1136/postgradmedj-2014-132983. [Epub ahead of print]

PMID:
25814511
2.

Adjuvant chemotherapy for breast cancer in a patient with primary autoimmune neutropenia.

Trus M, Dhamanaskar K, Potts J, Wasi P, Bains S, Bordeleau L.

Breast Cancer (Auckl). 2013;7:1-6. doi: 10.4137/BCBCR.S10767. Epub 2013 Feb 7.

3.

Quality of discharge summaries prepared by first year internal medicine residents.

Legault K, Ostro J, Khalid Z, Wasi P, You JJ.

BMC Med Educ. 2012 Aug 15;12:77. doi: 10.1186/1472-6920-12-77.

4.

"Might" or "suggest"? No wording approach was clearly superior in conveying the strength of recommendation.

Akl EA, Guyatt GH, Irani J, Feldstein D, Wasi P, Shaw E, Shaneyfelt T, Levine M, Schünemann HJ.

J Clin Epidemiol. 2012 Mar;65(3):268-75. doi: 10.1016/j.jclinepi.2011.08.001. Epub 2011 Nov 9.

PMID:
22075112
5.

Science and Technology for Disease Control: Past, Present, and Future.

Weatherall D, Greenwood B, Chee HL, Wasi P.

In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 5.

6.

A low-fidelity simulation curriculum addresses needs identified by faculty and improves the comfort level of senior internal medicine resident physicians with inhospital resuscitation.

Healey A, Sherbino J, Fan J, Mensour M, Upadhye S, Wasi P.

Crit Care Med. 2010 Sep;38(9):1899-903. doi: 10.1097/CCM.0b013e3181eb3ca9.

PMID:
20639751
7.

Predictive validity of the multiple mini-interview for selecting medical trainees.

Eva KW, Reiter HI, Trinh K, Wasi P, Rosenfeld J, Norman GR.

Med Educ. 2009 Aug;43(8):767-75. doi: 10.1111/j.1365-2923.2009.03407.x.

PMID:
19659490
8.

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.

Treon SP, Branagan AR, Ioakimidis L, Soumerai JD, Patterson CJ, Turnbull B, Wasi P, Emmanouilides C, Frankel SR, Lister A, Morel P, Matous J, Gregory SA, Kimby E.

Blood. 2009 Apr 16;113(16):3673-8. doi: 10.1182/blood-2008-09-177329. Epub 2008 Nov 17.

9.

Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.

Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR.

J Clin Oncol. 2005 Jun 20;23(18):4063-9. Epub 2005 Mar 14.

10.

Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma.

Wood LJ, Sehmi R, Dorman S, Hamid Q, Tulic MK, Watson RM, Foley R, Wasi P, Denburg JA, Gauvreau G, O'Byrne PM.

Am J Respir Crit Care Med. 2002 Sep 15;166(6):883-9.

PMID:
12231502
11.

Genetic factors affecting clinical severity in beta-thalassemia syndromes.

Winichagoon P, Fucharoen S, Chen P, Wasi P.

J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):573-80. Review.

PMID:
11132233
12.

Clinical manifestation of beta-thalassemia/hemoglobin E disease.

Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P.

J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):552-7.

PMID:
11132229
13.

A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia.

Pootrakul P, Sirankapracha P, Hemsorach S, Moungsub W, Kumbunlue R, Piangitjagum A, Wasi P, Ma L, Schrier SL.

Blood. 2000 Oct 1;96(7):2606-12.

14.

The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation.

Humar A, O'Rourke K, Lipton J, Messner H, Meharchand J, Mahony J, Walker I, Wasi P, McGeer A, Moussa G, Chua R, Mazzulli T.

Bone Marrow Transplant. 1999 Jan;23(1):45-51.

15.

Failure of pulse high-dose dexamethasone in chronic idiopathic immune thrombocytopenia.

Warner M, Wasi P, Couban S, Hayward C, Warkentin T, Kelton JG.

Am J Hematol. 1997 Apr;54(4):267-70.

PMID:
9092679
16.

Presence of immunoglobulins, C3 and cytolytic C5b-9 complement components on the surface of erythrocytes from patients with beta-thalassaemia/HbE disease.

Malasit P, Mahasorn W, Mongkolsapaya J, Singhathong B, Fucharoen S, Wasi P, Bhakdi S.

Br J Haematol. 1997 Mar;96(3):507-13.

PMID:
9054657
17.

Human genomics: implications for health.

Wasi P.

Southeast Asian J Trop Med Public Health. 1997;28 Suppl 2:19-24.

PMID:
9561633
18.

Severity of beta-thalassemia due to genotypes involving the IVS-I-6 (T-->C) mutation.

Waye JS, Eng B, Patterson M, Wasi P, Chui DH, Francombe WH, Sher GD, Olivieri NF.

Am J Hematol. 1995 Sep;50(1):15-9.

PMID:
7668219
19.
20.

Activation of monocytes for the immune clearance of red cells in beta zero-thalassaemia/HbE.

Wanachiwanawin W, Siripanyaphinyo U, Fucharoen S, Wasi P, Mawas F, Wiener E, Wickramasinghe SN.

Br J Haematol. 1993 Dec;85(4):773-7.

PMID:
7918042
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk